NEVVI Medicare utilization intelligence

← back

LIN, JEFFREYD.O. NPI 1639622665 Clinician

Infectious Disease · FORT WALTON BEACH, FL

Specialty Infectious Disease — from billed Medicare claims
Trained PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE — medical school, self-reported to CMS
In practice about 10 years since medical school (class of 2016, self-reported to CMS)
Location FORT WALTON BEACH, FL · NPPES registered location
Active in data Billed Medicare 2021–2024 (4 consecutive years)
Scale 50 codes billed · 3,012,728 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20222026
EMERALD COAST INFECTIOUS DISEASES MEDICAL GROUP, P.A.
2022–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2024-05

Year: 2024 · 2023 · 2022  · 2021 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0878 Injection, daptomycin, 1 mg
J0872 Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
J7336 Capsaicin 8% patch, per square centimeter
J0121 Injection, omadacycline, 1 mg
J2406 Injection, oritavancin (kimyrsa), 10 mg
J0696 Injection, ceftriaxone sodium, per 250 mg
J1306 Injection, inclisiran, 1 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J1335 Injection, ertapenem sodium, 500 mg
J0897 Injection, denosumab, 1 mg
J0692 Injection, cefepime hydrochloride, 500 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
99291 Critical care, first 30-74 minutes
J2405 Injection, ondansetron hydrochloride, per 1 mg
J2919 Injection, methylprednisolone sodium succinate, 5 mg
96375 Injection of additional new drug or substance into vein
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
J1200 Injection, diphenhydramine hcl, up to 50 mg
11042 Removal of skin and tissue, 20.0 sq cm or less
97597 Removal of tissue from wound, 20.0 sq cm or less
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96361 Infusion into a vein for hydration, each additional hour
96372 Injection of drug or substance under skin or into muscle
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96360 Infusion into a vein for hydration, 31-60 minutes
J7050 Infusion, normal saline solution, 250 cc
64999 Other procedure on nervous system
90480 Admn sarscov2 vacc 1 dose
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
91322 Sarscov2 vac 50 mcg/0.5ml im
G0008 Administration of influenza virus vaccine
90662 Influenza vaccine split virus, preservative free
99497 Advance care planning, first 30 minutes
36415 Insertion of needle into vein for collection of blood sample
97605 Therapy procedure using a special bandage and vacuum pump, surface area 50.0 sq cm or less
J3489 Injection, zoledronic acid, 1 mg
15275 Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less
G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J1940 Injection, furosemide, up to 20 mg
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and
91320 Sarscv2 vac 30mcg trs-suc im

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.